These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5083452)

  • 21. [On the analytical results obtained with a controlled production according to the modern "standards of good manufacture"].
    Mascellani G; Rocchi B
    Boll Chim Farm; 1971 Apr; 110(4):197-206. PubMed ID: 5111345
    [No Abstract]   [Full Text] [Related]  

  • 22. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immodest proposal.
    Dunn RR
    Soc Policy; 1983; 13(3):27-8. PubMed ID: 10260488
    [No Abstract]   [Full Text] [Related]  

  • 24. Product development of probiotics as biological drugs.
    Sutton A
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S128-32; discussion S144-51. PubMed ID: 18181718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiopharmaceutical production--radiation safety.
    Fredrickson RL; Myers CB
    IMS Ind Med Surg; 1969 Jul; 38(7):199-204. PubMed ID: 5256328
    [No Abstract]   [Full Text] [Related]  

  • 27. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA; Samsom RJ
    Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
    [No Abstract]   [Full Text] [Related]  

  • 28. Retesting and laboratory investigations.
    Davis JS
    J Pharm Sci Technol; 1994; 48(3):107-9. PubMed ID: 8069512
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 30. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
    Gnoth S; Jenzsch M; Simutis R; Lübbert A
    J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 2002; 902():i-vii, 1-208. PubMed ID: 12082969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499
    [No Abstract]   [Full Text] [Related]  

  • 34. Sevoflurane: are there differences in products?
    Baker MT
    Anesth Analg; 2007 Jun; 104(6):1447-51, table of contents. PubMed ID: 17513639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and use of drug master files in the pharmaceutical industry.
    Personeus GR; Ascione P
    J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835
    [No Abstract]   [Full Text] [Related]  

  • 36. Compounding and repackaging--a need for complete records.
    Proksch RA
    Hosp Pharm; 1980 Jul; 15(7):344-5, 349-50, 352-5. PubMed ID: 10247655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico.
    Schwertner HA; Storrow AB
    Clin Ther; 2005 May; 27(5):609-15. PubMed ID: 15978310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Security and quality control principles in the pharmaceutical industry].
    Garcia FF
    Boll Chim Farm; 1980 Oct; 119(10):569-73. PubMed ID: 7213473
    [No Abstract]   [Full Text] [Related]  

  • 39. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.
    Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality assurance of manufacturer-supplied unit dose packages.
    Pray S
    Hosp Pharm; 1979 Feb; 14(2):66, 68, 70-1. PubMed ID: 10240585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.